Bulk Manufacturer of Controlled Substances Application: AMPAC Fine Chemicals Virginia, LLC, 21810 [2019-10013]
Download as PDF
<![CDATA[
21810
Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices
hearing on the application on or before
June 14, 2019.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on March
12, 2019, Wildlife Laboratories, Inc.,
1230 West Ash, Suite D, Windsor,
Colorado 80550–4677 applied to be
registered as an importer of the
following basic class of controlled
substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Etorphine HCL ...............
Thiafentanil ....................
Drug code
9059
9729
Schedule
II
II
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[FR Doc. 2019–10013 Filed 5–14–19; 8:45 am]
[Docket No. DEA–392]
jbell on DSK3GLQ082PROD with NOTICES
Dated: April 27, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–10030 Filed 5–14–19; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
22:43 May 14, 2019
BILLING CODE 4410–09–P
Bulk Manufacturer of Controlled
Substances Application: AMPAC Fine
Chemicals Virginia, LLC
Notice of application.
[Docket No. DEA–392]
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before July 15, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on March
6, 2019, AMPAC Fine Chemicals
Virginia, LLC, 2820 North Normandy
Drive, Petersburg, Virginia 23805
applied to be registered as a bulk
manufacturer of the following basic
class of controlled substances:
SUPPLEMENTARY INFORMATION:
Methylphenidate .............
Phenylacetone ...............
Levomethorphan ............
Levorphanol ...................
Morphine ........................
Thebaine ........................
Noroxymorphone ...........
Tapentadol .....................
Drug code
1724
8501
9210
9220
9300
9333
9668
9780
Schedule
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Jkt 247001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
ACTION:
Controlled substance
The company plans to import the
listed controlled substances for
distribution to its customers.
Dated: April 27, 2019.
John J. Martin,
Assistant Administrator.
PO 00000
Frm 00063
Fmt 4703
Sfmt 9990
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as bulk
manufacturers of schedule I and II
controlled substances.
SUMMARY:
The
companies listed below applied to be
registered as bulk manufacturers of
schedule I or schedule II controlled
substances. Information on previously
published notices is listed in the table
below. No comments or objections were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
Company
Johnson Matthey Pharmaceutical Materials Inc.
IsoSciences, LLC ..............
FR docket
84 FR 2579
84 FR 2570
Published
February 7,
2019.
February 7,
2019.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of these registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed companies.
Dated: April 27, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–10014 Filed 5–14–19; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 84, Number 94 (Wednesday, May 15, 2019)]
[Notices]
[Page 21810]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10013]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: AMPAC
Fine Chemicals Virginia, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before July 15, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on March
6, 2019, AMPAC Fine Chemicals Virginia, LLC, 2820 North Normandy Drive,
Petersburg, Virginia 23805 applied to be registered as a bulk
manufacturer of the following basic class of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Methylphenidate...................... 1724 II
Phenylacetone........................ 8501 II
Levomethorphan....................... 9210 II
Levorphanol.......................... 9220 II
Morphine............................. 9300 II
Thebaine............................. 9333 II
Noroxymorphone....................... 9668 II
Tapentadol........................... 9780 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Dated: April 27, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-10013 Filed 5-14-19; 8:45 am]
BILLING CODE 4410-09-P
